The treatment of severe malaria.
In the SEAQUAMAT trial, parenteral artesunate was shown to be associated with a considerably lower mortality than quinine, and is now the recommended treatment for severe malaria in low-transmission areas and in the second and third trimesters of pregnancy. A trial is underway to establish its role...
Main Authors: | Dondorp, A, Day, N |
---|---|
格式: | Journal article |
语言: | English |
出版: |
2007
|
相似书籍
-
The management of patients with severe malaria.
由: Day, N, et al.
出版: (2007) -
The treatment of severe malaria
由: Dondorp, A
出版: (2007) -
UK recommendations for severe malaria are worrying.
由: White, N, et al.
出版: (2007) -
Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial.
由: Dondorp, A, et al.
出版: (2005) -
Malaria treatment in the United States.
由: Hanson, J, et al.
出版: (2007)